3The Rotterdam ESHRE/ASRM -Sponsored PCOS Consensus Work- shop Group. Revised 2003 consensus on diagnostic criteria and long - term health risks related to polycystic ovary syndrome[ J]. Fertil Ster- i1,2004,81 ( 1 ) : 19 - 25.
4Spritzer PM, Lisboa KO, Maltiello S, et al. Spironolactone as a sin-gleagent for long - term therapy of hirsute patients [ J ]. Clin Endocri- onl(Oxf) ,2007,52 ( 5 ) :587 - 594.
5Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial [ J ]. Fertil Steril, 2009,92 ( 3 ) : 849 - 852.
6Chekir C, Nakatsuka M, Kamada Y, et al. Impaired uterine perfu- sion associated with metabolic disorders in women with polycystic ova- ry syndrome [ J ]. Aeta Obstet Gynecol Scand, 2005,84 ( 2 ) : 189 - 195.
